Abbott Laboratories (ABT) Receivables (2009 - 2026)
Abbott Laboratories (ABT) posted Receivables of $8.6 billion for Q2 2026, up 4.74% sequentially from $8.2 billion in Q1 2026, and up 7.87% YoY from $8.0 billion in Q2 2025.
Abbott Laboratories (ABT) Receivables (2009 - 2026) Analysis & Trends
Abbott Laboratories has reported Receivables for 18 years, with the latest figure at $8.6 billion in Q2 2026.
- Quarterly Receivables rose 7.87% year-over-year to $8.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.6 billion (up 7.87% YoY) and the FY2025 annual result came in at $7.9 billion, up 14.5% from the prior year.
- Receivables climbed to $8.6 billion in Q2 2026 per ABT's latest filing, from $8.2 billion in the prior quarter.
- Over five years, Receivables peaked at $8.6 billion in Q2 2026 and troughed at $6.0 billion in Q1 2023.
- A 5-year average of $7.1 billion and a median of $7.0 billion in 2024 frame the typical range for Receivables.
- The sharpest annual moves came in 2022 and 2023: Receivables increased 17.77% in 2022, then retreated 16.14% in 2023.
- Over 5 years, Receivables stood at $6.2 billion in 2022, then gained by 5.58% to $6.6 billion in 2023, then rose by 5.48% to $6.9 billion in 2024, then grew by 14.5% to $7.9 billion in 2025, then gained by 8.45% to $8.6 billion in 2026.
- According to Business Quant data, Receivables over the past three periods registered $8.6 billion, $8.2 billion, and $7.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 8.60 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 3.74 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 3.18 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 955.70 Mn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 1.28 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 4.66 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 4.12 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 1.01 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 1.77 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.60 Bn |
| Mar 31, 2026 | 8.21 Bn |
| Dec 31, 2025 | 7.93 Bn |
| Sep 30, 2025 | 8.14 Bn |
| Jun 30, 2025 | 7.97 Bn |
| Mar 31, 2025 | 7.33 Bn |
| Dec 31, 2024 | 6.93 Bn |
| Sep 30, 2024 | 7.05 Bn |
| Jun 30, 2024 | 6.85 Bn |
| Mar 31, 2024 | 6.61 Bn |
| Dec 31, 2023 | 6.57 Bn |
| Sep 30, 2023 | 6.50 Bn |
| Jun 30, 2023 | 6.17 Bn |
| Mar 31, 2023 | 6.02 Bn |
| Dec 31, 2022 | 6.22 Bn |
| Sep 30, 2022 | 6.41 Bn |
| Jun 30, 2022 | 7.20 Bn |
| Mar 31, 2022 | 7.18 Bn |
| Dec 31, 2021 | 6.49 Bn |
| Sep 30, 2021 | 6.41 Bn |